Company profile
BiPER Therapeutics
First in class small molecules pushing cancer cells to burn out
- Industry
- Biotechnology Research
- Employees
- 15
- Headquarters
- STRASBOURG
- Founded
- 2021
- Office locations
- 1
BiPER Therapeutics company summary
BiPER Therapeutics is a company in the Biotechnology Research industry, headquartered in STRASBOURG, founded in 2021. On LinkedIn the company has around 15 employees.
What technology does BiPER Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About BiPER Therapeutics
BiPER Therapeutics is developing a first-in-class pipeline of therapeutics overstressing cells to cure patients. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer
Where is BiPER Therapeutics located?
BiPER Therapeutics lists 1 location.
Compare companies similar to BiPER Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
BiPER Therapeutics biper-tx.com | Biotechnology Research | 15 | 2021 | STRASBOURG |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about BiPER Therapeutics
What does BiPER Therapeutics do?
BiPER Therapeutics is developing a first-in-class pipeline of therapeutics overstressing cells to cure patients. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer
How many employees does BiPER Therapeutics have?
BiPER Therapeutics has around 15 employees on LinkedIn.
Where is BiPER Therapeutics headquartered?
BiPER Therapeutics is headquartered in STRASBOURG.
When was BiPER Therapeutics founded?
BiPER Therapeutics was founded in 2021.
Build a lead list from companies like BiPER Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.